R
RenovoRx D
D
RNXT
1.33500
USD
-0.07
(-4.64%)
مفتوح الان
حجم التداول
36
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
48,823,930
العنوان: RenovoRx
القطاع: Healthcare
الصناعة: Biotechnology
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.